Laporan Laba Rugi HKMPY - TTM - Hikma Pharmaceuticals PLC - Depositary Receipt (Common Stock)

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Hikma Pharmaceuticals PLC - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	2,316	2,341	2,383	2,425	2,489	2,553	2,552	2,550	2,534	2,517	2,624	2,731	2,803	2,875	2,946	3,017	3,072	3,127	3,172	3,216
Change (%)		1.06	1.79	1.76	2.64	2.57	-0.06	-0.06	-0.65	-0.65	4.25	4.08	2.64	2.57	2.47	2.41	1.82	1.79	1.42	1.40
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	1,134	1,128	1,150	1,173	1,212	1,252	1,247	1,242	1,247	1,252	1,313	1,374	1,421	1,468	1,518	1,569	1,640	1,712	1,772	1,832
Change (%)		-0.53	1.99	1.96	3.37	3.26	-0.40	-0.40	0.40	0.40	4.87	4.65	3.42	3.31	3.44	3.33	4.56	4.36	3.50	3.39
% of Revenue	48.95	48.18	48.28	48.37	48.71	49.04	48.87	48.71	49.22	49.74	50.04	50.31	50.70	51.06	51.54	52.01	53.40	54.75	55.87	56.97

Gross Operating Profit	1,182	1,213	1,232	1,252	1,276	1,301	1,304	1,308	1,286	1,265	1,311	1,357	1,382	1,407	1,428	1,448	1,432	1,415	1,400	1,384
Change (%)		2.58	1.61	1.58	1.96	1.92	0.27	0.27	-1.64	-1.67	3.64	3.51	1.84	1.81	1.46	1.44	-1.14	-1.15	-1.10	-1.11
% of Revenue	51.05	51.82	51.72	51.63	51.29	50.96	51.13	51.29	50.78	50.26	49.96	49.69	49.30	48.94	48.46	47.99	46.60	45.25	44.13	43.03

SG&A	503	506	508	509	535	561	573	585	593	601	604	606	619	632	642	651	656	662	661	660
Change (%)		0.60	0.30	0.30	5.11	4.86	2.14	2.09	1.37	1.35	0.42	0.41	2.15	2.10	1.50	1.48	0.84	0.84	-0.15	-0.15
% of Revenue	21.71	21.61	21.30	20.99	21.49	21.97	22.46	22.94	23.41	23.88	23.00	22.19	22.08	21.98	21.78	21.58	21.37	21.17	20.84	20.52

R&D	134	137	136	134	138	143	148	153	148	144	142	139	144	149	148	146	144	141	147	153
Change (%)		2.62	-1.09	-1.11	3.36	3.25	3.50	3.38	-2.94	-3.03	-1.74	-1.77	3.60	3.47	-1.01	-1.02	-1.71	-1.74	4.26	4.08
% of Revenue	5.76	5.85	5.69	5.53	5.56	5.60	5.80	6.00	5.86	5.72	5.39	5.09	5.14	5.18	5.01	4.84	4.67	4.51	4.64	4.76

OpEx	1,790	1,801	1,830	1,858	1,925	1,992	1,997	2,002	2,010	2,019	2,120	2,220	2,235	2,250	2,274	2,299	2,409	2,519	2,578	2,636
Change (%)		0.59	1.58	1.56	3.61	3.48	0.25	0.25	0.42	0.42	4.98	4.74	0.68	0.67	1.09	1.08	4.78	4.57	2.32	2.27
% of Revenue	77.29	76.93	76.77	76.62	77.34	78.03	78.27	78.51	79.36	80.21	80.77	81.29	79.74	78.26	77.21	76.20	78.42	80.56	81.27	81.97

Operating Income	526	540	554	567	564	561	554	548	523	498	504	511	568	625	672	718	663	608	594	580
Change (%)		2.66	2.50	2.44	-0.53	-0.53	-1.16	-1.17	-4.56	-4.78	1.31	1.29	11.15	10.04	7.44	6.92	-7.66	-8.30	-2.30	-2.36
% of Revenue	22.71	23.07	23.23	23.38	22.66	21.97	21.73	21.49	20.64	19.79	19.23	18.71	20.26	21.74	22.79	23.80	21.58	19.44	18.73	18.03

Interest Expense	-38	-41	-42	-42	-42	-43	-47	-51	-55	-59	-64	-70	-72	-73	-73	-73	-74	-75	-73	-71
Change (%)		7.89	1.22	1.20	1.19	1.18	9.30	8.51	7.84	7.27	9.32	8.53	2.14	2.10	-0.00	-0.00	1.37	1.35	-2.67	-2.74
% of Revenue	-1.64	-1.75	-1.74	-1.73	-1.71	-1.68	-1.84	-2.00	-2.17	-2.34	-2.46	-2.56	-2.55	-2.54	-2.48	-2.42	-2.41	-2.40	-2.30	-2.21

Net Income	472	431	449	467	444	421	384	346	267	188	167	146	168	190	238	285	322	359	365	371
Change (%)		-8.69	4.18	4.01	-4.93	-5.18	-8.91	-9.78	-22.83	-29.59	-11.17	-12.57	15.07	13.10	25.00	20.00	12.98	11.49	1.67	1.64
% of Revenue	20.38	18.41	18.84	19.26	17.84	16.49	15.03	13.57	10.54	7.47	6.36	5.35	5.99	6.61	8.06	9.45	10.48	11.48	11.51	11.54

Source: Capital IQ

Hikma Pharmaceuticals PLC - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)